Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use

Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use

US Patent 10980801 · Granted Apr 20, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cerdulatinib for the treatment of b-cell malignancies2025
Compositions for management of polycystic ovary syndrome2025
Substituted pyridines, pyridazines, pyrimidines, and 1,2,4-triazines as TYK2 inh2024
Portable solar-powered devices2024
Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (P2024
Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (P2024
Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (P2024
Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (P2024
Substituted pyridines and pyridazines as TYK2 inhibitors2024
Substituted pyridines, pyridazines, and pyrimidines as TYK2 inhibitors2024
Phenylalanine small organic compounds to directly modulate PCSK9 protein activit2024
Phenylalanine small organic compounds to directly modulate PCSK9 protein activit2024